Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Unity Biotechnology Inc (NASDAQ: UBX) closed the day trading at $0.38 down -50.21% from the previous closing price of $0.77. In other words, the price has decreased by -$50.21 from its previous closing price. On the day, 2.21 million shares were traded. UBX stock price reached its highest trading level at $0.72 during the session, while it also had its lowest trading level at $0.36.
Ratios:
For a better understanding of UBX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.95 and its Current Ratio is at 1.95.
On May 16, 2025, Mizuho Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $6 to $1.
On August 22, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $8.Rodman & Renshaw initiated its Buy rating on August 22, 2024, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’25 when Nguyen Alexander Hieu sold 17,852 shares for $1.03 per share. The transaction valued at 18,388 led to the insider holds 48,753 shares of the business.
Nguyen Alexander Hieu bought 17,852 shares of UBX for $18,305 on Apr 02 ’25. On Apr 02 ’25, another insider, Sullivan Lynne Marie, who serves as the CFO & Head of Corp. Dev. of the company, sold 21,867 shares for $1.03 each. As a result, the insider received 22,523 and left with 98,905 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UBX now has a Market Capitalization of 6611206 and an Enterprise Value of 12285195.
Stock Price History:
The Beta on a monthly basis for UBX is 1.08, which has changed by -0.7068702 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, UBX has reached a high of $3.10, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -53.85%, while the 200-Day Moving Average is calculated to be -70.57%.
Shares Statistics:
Over the past 3-months, UBX traded about 274.39K shares per day on average, while over the past 10 days, UBX traded about 315950 shares per day. A total of 17.21M shares are outstanding, with a floating share count of 15.68M. Insiders hold about 8.92% of the company’s shares, while institutions hold 11.46% stake in the company. Shares short for UBX as of 1749772800 were 572503 with a Short Ratio of 2.09, compared to 1747267200 on 749059. Therefore, it implies a Short% of Shares Outstanding of 572503 and a Short% of Float of 3.39.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are keenly observing as 3.0 analysts analyze and rate the current performance of Unity Biotechnology Inc (UBX) in the stock market.The consensus estimate for the next quarter is -$0.15, with high estimates of $0.0 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$0.49 and -$1.27 for the fiscal current year, implying an average EPS of -$0.89. EPS for the following year is -$0.82, with 4.0 analysts recommending between -$0.68 and -$1.0.
